Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02504580 · ClinicalTrials.gov registry record · Phase 2
Pilot Herniorrhaphy Study for Postoperative Analgesia
A Phase 2 study of Postoperative Pain, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 463
- Enrollment target
- 3
- Study locations
NCT02504580: Completed Phase 2 study of Postoperative Pain, sponsored by Heron Therapeutics.
NCT02504580 is a Phase 2 study of Postoperative Pain that has completed, run by Heron Therapeutics. The registered enrollment target is 463 participants, above the 228-participant average among 120 other Postoperative Pain trials with a reported enrollment target (103% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02504580, a Phase 2 study of Postoperative Pain, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 463 participants
- Enrollment target
- 3
- Study locations
Study Summary
A Phase 2, Randomized, Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy
Primary Outcome
Subjects assessed pain intensity for their current pain with the 11-point (0 to 10) Numeric Rating Scale NRS where "0" equated to "no pain" and "10" equated to "the worst pain imaginable". Pain intensity was assessed at rest (NRS-R) after the subject had been supine for a minimum of 5 minutes and with activity (NRS-A) sitting up from a supine position. The SPI is derived by summing the pain intensity score weighted by the scheduled time duration. SPI0-24 was calculated by summing the Pain intens
Conditions Studied
Interventions
- DRUG Placebo
- DRUG HTX-011
- DRUG HTX-002
- DRUG Bupivacaine HCI (Marcaine)
- DRUG HTX-011A
Study Locations (3)
Texas
- - Houston
- - Houston
California
- - Anaheim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 2 |
What the finished NCT02504580 record still lists
NCT02504580 is an interventional study that assigns participants to a tested intervention. The registered 463 participants enrollment target is mid-sized for trials with a published cap, above the 228-participant average among 120 other Postoperative Pain trials with a reported enrollment target (103% higher).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT02504580 reports a single indexed study location in Texas, California.
Frequently Asked Questions
What is clinical trial NCT02504580 about?
NCT02504580 is a clinical study titled "Pilot Herniorrhaphy Study for Postoperative Analgesia". A Phase 2, Randomized, Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy
What is the current status of trial NCT02504580?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 463 participants. The study started on 2015-07. Estimated completion is 2017-04.
What conditions does trial NCT02504580 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT02504580?
The interventions under investigation include: Placebo (DRUG), HTX-011 (DRUG), HTX-002 (DRUG), Bupivacaine HCI (Marcaine) (DRUG), HTX-011A (DRUG).
Who is sponsoring clinical trial NCT02504580?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02504580 being conducted?
This trial has 3 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02504580's enrollment target sits among peer trials
463 10th of 120 higher than 111 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
-
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
RECRUITING · Phase 2
-
Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
RECRUITING · Phase 2
-
Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy
COMPLETED · Phase 2
-
Phase 2 Bunionectomy HTX-011 Administration Study
COMPLETED · Phase 2
-
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia